Brucine Suppresses Malignant Progression of Prostate Cancer by Decreasing Sarcosine Accumulation via Downregulation of GNMT in the Glycine/sarcosine Metabolic Pathway
- PMID: 38877335
- DOI: 10.1007/s12013-024-01348-z
Brucine Suppresses Malignant Progression of Prostate Cancer by Decreasing Sarcosine Accumulation via Downregulation of GNMT in the Glycine/sarcosine Metabolic Pathway
Abstract
Prostate cancer (PCa) remains a leading cause of cancer-related incidence and mortality in men. Disruptions in amino acid (AA) metabolism contribute to the disease progression, with brucine, a glycine antagonist, exhibiting antitumor effects. This study explores the antitumor impact of brucine on PCa and investigates its mechanisms in regulating AA metabolic pathways. The study employed the PCa cell line DU-145, characterized by high sarcosine (Sar) levels, for various assays including Cell Counting Kit-8 (CCK8), wound healing, Transwell, 5-Ethynyl-2'-deoxyuridine (EDU), TdT mediated dUTP Nick End Labeling (TUNEL), flow cytometry, Western blot, and ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Network pharmacological analysis determined the anticancer mechanisms of brucine. Sar levels in DU-145 cells were significantly higher than in normal prostatic epithelial cells RWPE-1. Treatment with brucine resulted in a marked decrease in cell viability, proliferation, invasion, and migration, while promoting apoptosis in a dose-dependent manner. Sar levels decreased with increasing brucine concentration. Network pharmacology analysis linked brucine's anticancer effect to the AA metabolism and glycine N-methyltransferase (GNMT) pathways. GNMT expression in prostate cancer tissues and The Cancer Genome Atlas database was significantly elevated compared to controls. Treatment with brucine led to downregulation of GNMT expression in DU-145 cells without significant effect on sarcosine dehydrogenase (SARDH). Addition of recombinant GNMT partially reversed the inhibitory effects of brucine on DU-145 cells. Treatment with brucine downregulates GNMT expression in DU-145 cells, reducing Sar accumulation and inhibiting tumor progression. These findings provide new insights into the antitumor mechanisms of brucine in PCa.
Keywords: Amino acid metabolism; Apoptosis; Brucine; Proliferation; Prostate cancer.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.Prostate. 2016 May;76(7):679-90. doi: 10.1002/pros.23159. Epub 2016 Feb 5. Prostate. 2016. PMID: 26847870
-
The role of sarcosine metabolism in prostate cancer progression.Neoplasia. 2013 May;15(5):491-501. doi: 10.1593/neo.13314. Neoplasia. 2013. PMID: 23633921 Free PMC article.
-
The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer.Mod Pathol. 2011 Sep;24(9):1272-80. doi: 10.1038/modpathol.2011.76. Epub 2011 May 13. Mod Pathol. 2011. PMID: 21572396
-
The complex role of glycine N-methyltransferase in metabolism-a review.Mol Biol Rep. 2025 Mar 1;52(1):271. doi: 10.1007/s11033-025-10374-w. Mol Biol Rep. 2025. PMID: 40025311 Review.
-
Glycine and aging: Evidence and mechanisms.Ageing Res Rev. 2023 Jun;87:101922. doi: 10.1016/j.arr.2023.101922. Epub 2023 Mar 31. Ageing Res Rev. 2023. PMID: 37004845 Review.
References
-
- Saeidi, H., Ismail, P., & Samudi Raju, C., et al. (2023). Genetic alterations in prostate cancer as diagnostic and prognostic markers. Malaysian Journal of Pathology, 45(2), 149–155. - PubMed
-
- Washington, C., Goldstein, D. A., & Moore, A., et al. (2022). Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care. American Society of Clinical Oncology Educational Book, 42, 1–6. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous